1PC
11-09
$1T pay package approved 💥—Tesla shareholders back Musk’s moonshot plan 🚀. Can he hit the milestones[Doubt] With his track record, never say never[Surprised]. But after the hype, is this a “Sell the News” moment[Drowsy]? Maybe Short term. Long term, I still see Tesla as a conviction hold 🔋📈[Duh]. Innovation, scale, and Musk’s skin in the game = Powerful Combo[Miser]. @JC888 @Barcode @Shyon @koolgal @Shernice軒嬣 2000 @Aqa @DiAngel
1 Trln Pay Package Approved! Tesla Sell the News: Hold for Long Term?
On November 6, more than 75% of shareholders voted in favor of Tesla CEO Elon Musk’s new compensation package. Under the plan, if Musk meets a series of milestones over the next ten years, he will gradually receive about 423.7 million restricted stock units (RSUs) — up to USD 1 trillion. Can Musk realistically hit these ambitious milestones in the next decade? Will this massive pay package truly align Tesla’s growth with shareholder interests After the approval, is Tesla a “sell the news” trade — or a long-term conviction hold?
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

  • koolgal
    11-09
    koolgal
    Elon Musk is the type that says  "Die die must try. 😁😁😁
    • 1PC
      [LOL] [LOL] [LOL] ✋✋
  • Enid Bertha
    11-10
    Enid Bertha
    Total blast off today $500 within reach.

  • Venus Reade
    11-10
    Venus Reade
    Tesla. The only stock that can double while earnings get cut in half.

Leave a comment
4
2